Persephoni Bio
Venture Capital and Private Equity Principals • 
8 Davis Dr, Suite 338, United States • 11-20 Employees
Company overview
| Headquarters | 8 Davis Dr, Suite 338, Research Triangle Park, North Carolina 27709, US |
| Website | |
| NAICS | 52391 |
| Keywords | Executive Leadership, Venture Capital, Private Equity, Biotech, Investment, Company Formation, Fund Management, Fundraising, Therapeutics, Lifesciences, Research An Development |
| Founded | 2024 |
| Employees | 11-20 |
| Socials |
Key Contacts at Persephoni Bio
Hilary Schultz
Chief Executive Officer
Michaela Copp
Director
Andrew Petryna
Director Of Portfolio
Lisa Puccetti
Director Of Business Operations
Persephoni Bio Email Formats
Persephoni Bio uses 2 email formats. The most common is {first name} (e.g., john@persephonibio.com), used 78.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@persephonibio.com | 78.6% |
{first initial} | j@persephonibio.com | 21.4% |
About Persephoni Bio
Persephoni | Turning scientific breakthroughs into real world therapeutics At Persephoni, we have assembled the industry's finest to transform breakthrough discoveries into life-changing therapies. Guided by the belief that innovation thrives at the intersection of bold science and strategic execution, we de-risk early-stage biotechnology and therapeutics, enabling rapid advancement from bench to bedside. Our approached is grounded in the Persephoni BREAKTHROUGH SYSTEM, a hybrid Venture Studio and Private Equity model, and strategic capital deployment mechanisms with Global reach. Our unique approach combines company formation, hands-on operational support, and targeted capital deployment to accelerate preclinical & Clinical technologies toward value inflection points. By partnering with top scientific founders, leading research institutions, and strategic investors, we bridge the critical funding gap in life sciences, unlocking value and expediting treatments that matter. At Persephoni, we’re not just building companies—we’re redefining what's possible in biotech innovation.
Persephoni Bio revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Venture Capital and Private Equity Principals industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Persephoni Bio has 7 employees across 5 departments.
Departments
Number of employees
Funding Data
Persephoni Bio has never raised funding before.
Persephoni Bio Tech Stack
Discover the technologies and tools that power Persephoni Bio's digital infrastructure, from frameworks to analytics platforms.
Hosting
CMS
Miscellaneous
Security
Video players
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Belgium
Spain
Canada
South Africa
Frequently asked questions
4.8
40,000 users
